Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

An Extension Study of Trastuzuma Emtansine in Patients Previously Treated With Trastuzuma Emtansine

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Genentech, Inc.
ClinicalTrials.gov Identifier:
NCT00781612
First received: October 27, 2008
Last updated: July 21, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)